Turmeric, Extract (Curcuma Longa L.)
CAS 84775-52-0
Turmeric, Extract (Curcuma Longa L.) (CAS 84775-52-0) is a pharmaceutical compound with 0 bioactivity targets and 97 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
TURMERIC, EXTRACT (CURCUMA LONGA L.) is linked to DTXSID901041901 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Turmeric, Extract (Curcuma Longa L.) used for in pharmaceutical contexts?
Turmeric, Extract (Curcuma Longa L.) (CAS 84775-52-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Turmeric, Extract (Curcuma Longa L.)?
Turmeric, Extract (Curcuma Longa L.) has 97 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Asthenia, Blood pressure abnormal, Constipation, Decreased appetite, Diarrhoea. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Turmeric, Extract (Curcuma Longa L.) also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Turmeric Extract (Curcuma Longa Root Extract) with EU status "permitted".
What clinical phase is Turmeric, Extract (Curcuma Longa L.) in?
No phase 1-4 clinical development badge is rendered for Turmeric, Extract (Curcuma Longa L.) because the matched compound identifier rows do not contain a max-phase value.